Wave Life Sciences Ltd. (WVE): Why analyst showing interest


Wave Life Sciences Ltd. (NASDAQ:WVE) changes shares on Friday trading session, with a change of -0.63% or -$0.07 shares. The trading starts at $11.11 and closed at $11.13 throughout the day. The trading session low price was $10.76 and day high was $11.30 on Friday, June 26. After the session, the Healthcare sector daily volume shifted to 0.55 million while its average volume is 507.73K. In other hand, the WVE market cap reached to $383.78M. While, its current target price is $11.06 according to WSJ.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 2.79% and up 7.80% for month. Its quarterly performance was 19.83% above, while its half year performance is down -31.45%. WVE yearly performance stood at negative -57.87% and rise 37.99% for year-to-date. Current recommendation for Wave Life Sciences Ltd. is 2.10.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. WVE EPS (TTM) for 12-month is -5.74. EPS for this year is -12.90%, while for the next year its value is -2.48. Its EPS Q/Q reached -1.60%.

Let’s take a look on the analyst recommendations on WVE for the current month and previous month. For the current month, 5 of 8 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 3 as Hold. As compared with the previous month ratings, 8 analysts participate in stock recommendation. Out of 8, 0 rated it sell, 6 rated it as Buy and 2 as Hold Ratings. On the other hand, target price ranges from $8.00-$21.00. Average target price for WVE was reached at $16.71.

RA Capital Management, L.P., RTW Investments LP and Wellington Management Company, LLP are the top three holders in Wave Life Sciences Ltd. (WVE) stock. On Mar 30, 2020, RA Capital Management, L.P. has 7.78 million shares which valued 72.85 million. On Mar 30, 2020, RTW Investments LP owned 3.39 million shares which valued at 31.76 million. On Mar 30, 2020, Wellington Management Company, LLP has a total of 3.03 million shares which valued at 28.4 million. In the end, Wellington Management Company, LLP have 8.69% shares outstanding of Wave Life Sciences Ltd. (WVE) on Mar 30, 2020. The insider ownership moved to 1.20% and institutional holding shifted to 87.70%.

The company posted an EPS (TTM) of -5.74. According to the most recent quarter report on (Jun 2020), 8 analysts estimated an average EPS of -0.97, while -1.22 EPS posted a year ago period. Analyst Estimated EPS for WVE published in the report was -1.32–0.51 during the same period. Comparing with last year, the average estimated EPS was -1.22 which is higher than -1.38 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for WVE fall -26.06% for period of 200 days. SMA for 50 days was 15.09% which is showing green signal, while SMA-20 was 8.72%. The moving average value for Wave Life Sciences Ltd. (WVE) is 10.17 and 10.25 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in WVE stock. On Feb 18, Panzara Michael A., Chief Medical Officer, sold 2,981 trading shares at the cost of $7.85, which valued at 23401.0. On Feb 18, BOLNO PAUL, President and CEO, sold 11,451 shares at the cost of $7.85, with total shares of 319,758. On Feb 18, Francis Chris, See Remarks, sold 2,708 shares at the cost of 7.85. After this transaction, Francis Chris total shares reached to 31,160 which valued at 21258.0.